|
ZNF354B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.818200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.441400E-03 |
| Normal-vs-Stage2 |
1.220850E-01 |
| Normal-vs-Stage3 |
1.079350E-01 |
| Normal-vs-Stage4 |
4.015400E-01 |
| Stage1-vs-Stage2 |
5.336200E-01 |
| Stage1-vs-Stage3 |
7.329000E-01 |
| Stage1-vs-Stage4 |
7.578400E-01 |
| Stage2-vs-Stage3 |
4.476800E-01 |
| Stage2-vs-Stage4 |
9.668000E-01 |
| Stage3-vs-Stage4 |
6.869800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.448200E-04 |
| Normal-vs-AfricanAmerican |
2.327900E-02 |
| Normal-vs-Asian |
4.104800E-01 |
| Caucasian-vs-AfricanAmerican |
8.722200E-01 |
| Caucasian-vs-Asian |
5.923200E-01 |
| AfricanAmerican-vs-Asian |
6.780400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.170600E-04 |
| Normal-vs-Female |
4.484600E-03 |
| Male-vs-Female |
6.350200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.997900E-02 |
| Normal-vs-Extreme_Weight |
1.196170E-02 |
| Normal-vs-Obese |
4.217600E-03 |
| Normal-vs-Extreme_Obese |
6.044200E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.448000E-01 |
| Normal_Weight-vs-Obese |
6.277000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.692800E-01 |
| Extreme_Weight-vs-Obese |
4.709400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.250800E-01 |
| Obese-vs-Extreme_Obese |
7.861400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.707600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.36300000000522E-06 |
| Normal-vs-Age(61-80Yrs) |
5.057800E-02 |
| Normal-vs-Age(81-100Yrs) |
5.889800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.122020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.168800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.952000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.397920E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.108250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.931000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.40729999999578E-05 |
| Normal-VS-Type2 PRCC |
4.017400E-01 |
| Normal-VS-KIRP CIMP |
1.457640E-01 |
| Normal-VS-Unclassified PRCC |
6.717100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.983600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.8146299999966E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.868800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.963900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.797600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.841300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.161050E-01 |
| Normal-vs-N1 |
9.545600E-02 |
| Normal-vs-N2 |
8.219000E-01 |
| N0-vs-N1 |
2.985800E-01 |
| N0-vs-N2 |
8.070800E-01 |
| N1-vs-N2 |
5.829400E-01 |
|
|
